These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24504326)

  • 101. Successful Treatment of a Child With Epileptic Encephalopathy With Spike-Wave Activation in Sleep and GRIN2A Variant Using Sulthiame.
    Pereira-Nunes J; Sousa JM; Fonseca J; Melo C; Alves D; Sampaio M; Sousa R
    Cureus; 2023 Feb; 15(2):e34686. PubMed ID: 36909045
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The p.Glu787Lys variant in the GRIA3 gene causes developmental and epileptic encephalopathy mimicking structural epilepsy in a female patient.
    Martinez-Esteve Melnikova A; Pijuan J; Aparicio J; Ramírez A; Altisent-Huguet A; Vilanova-Adell A; Arzimanoglou A; Armstrong J; Palau F; Hoenicka J; San Antonio-Arce V
    Eur J Med Genet; 2022 Mar; 65(3):104442. PubMed ID: 35093607
    [TBL] [Abstract][Full Text] [Related]  

  • 103. A novel GRIN2B variant (p.F1340V) causes a severe neurodevelopmental disorder with refractory epileptic spasms.
    Kolosky T; Erdemir G
    Epileptic Disord; 2024 Jun; 26(3):395-397. PubMed ID: 38411992
    [No Abstract]   [Full Text] [Related]  

  • 104. Intrathecal magnesium delivery for Mg++-insensitive NMDA receptor activity due to GRIN1 mutation.
    Lewis SA; Shetty S; Gamble S; Heim J; Zhao N; Stitt G; Pankratz M; Mangum T; Marku I; Rosenberg RB; Wilfong AA; Fahey MC; Kim S; Myers SJ; Appavu B; Kruer MC
    Orphanet J Rare Dis; 2023 Aug; 18(1):225. PubMed ID: 37537625
    [TBL] [Abstract][Full Text] [Related]  

  • 105.
    Mir A; Qahtani M; Bashir S
    J Pediatr Genet; 2020 Dec; 9(4):252-257. PubMed ID: 32765929
    [TBL] [Abstract][Full Text] [Related]  

  • 106.
    Pierson TM; Yuan H; Marsh ED; Fuentes-Fajardo K; Adams DR; Markello T; Golas G; Simeonov DR; Holloman C; Tankovic A; Karamchandani MM; Schreiber JM; Mullikin JC; ; Tifft CJ; Toro C; Boerkoel CF; Traynelis SF; Gahl WA
    Ann Clin Transl Neurol; 2014 Mar; 1(3):190-198. PubMed ID: 24839611
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.
    Venkateswaran S; Myers KA; Smith AC; Beaulieu CL; Schwartzentruber JA; ; Majewski J; Bulman D; Boycott KM; Dyment DA
    Epilepsia; 2014 Jul; 55(7):e75-9. PubMed ID: 24903190
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
    Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
    Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Effect of a GRIN2A de novo mutation associated with epilepsy and intellectual disability on NMDA receptor currents and Mg(2+) block in cultured primary cortical neurons.
    Marwick K; Skehel P; Hardingham G; Wyllie D
    Lancet; 2015 Feb; 385 Suppl 1():S65. PubMed ID: 26312887
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.
    Yuan H; Low CM; Moody OA; Jenkins A; Traynelis SF
    Mol Pharmacol; 2015 Jul; 88(1):203-17. PubMed ID: 25904555
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 112. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
    Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
    PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
    [TBL] [Abstract][Full Text] [Related]  

  • 113. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
    Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ
    Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
    Hansen KB; Ogden KK; Yuan H; Traynelis SF
    Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study.
    Dyment DA; Tétreault M; Beaulieu CL; Hartley T; Ferreira P; Chardon JW; Marcadier J; Sawyer SL; Mosca SJ; Innes AM; Parboosingh JS; Bulman DE; Schwartzentruber J; Majewski J; Tarnopolsky M; Boycott KM; ;
    Clin Genet; 2015 Jul; 88(1):34-40. PubMed ID: 25046240
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Functional Evaluation of a De Novo
    Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
    Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
    [TBL] [Abstract][Full Text] [Related]  

  • 117. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.
    ; ;
    Am J Hum Genet; 2014 Oct; 95(4):360-70. PubMed ID: 25262651
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Investigation of GRIN2A in common epilepsy phenotypes.
    Lal D; Steinbrücker S; Schubert J; Sander T; Becker F; Weber Y; Lerche H; Thiele H; Krause R; Lehesjoki AE; Nürnberg P; Palotie A; Neubauer BA; Muhle H; Stephani U; Helbig I; Becker AJ; Schoch S; Hansen J; Dorn T; Hohl C; Lüscher N; ; ; von Spiczak S; Lemke JR
    Epilepsy Res; 2015 Sep; 115():95-9. PubMed ID: 26220384
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Towards the identification of a genetic basis for Landau-Kleffner syndrome.
    Conroy J; McGettigan PA; McCreary D; Shah N; Collins K; Parry-Fielder B; Moran M; Hanrahan D; Deonna TW; Korff CM; Webb D; Ennis S; Lynch SA; King MD
    Epilepsia; 2014 Jun; 55(6):858-65. PubMed ID: 24828792
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    Platzer K; Yuan H; Schütz H; Winschel A; Chen W; Hu C; Kusumoto H; Heyne HO; Helbig KL; Tang S; Willing MC; Tinkle BT; Adams DJ; Depienne C; Keren B; Mignot C; Frengen E; Strømme P; Biskup S; Döcker D; Strom TM; Mefford HC; Myers CT; Muir AM; LaCroix A; Sadleir L; Scheffer IE; Brilstra E; van Haelst MM; van der Smagt JJ; Bok LA; Møller RS; Jensen UB; Millichap JJ; Berg AT; Goldberg EM; De Bie I; Fox S; Major P; Jones JR; Zackai EH; Abou Jamra R; Rolfs A; Leventer RJ; Lawson JA; Roscioli T; Jansen FE; Ranza E; Korff CM; Lehesjoki AE; Courage C; Linnankivi T; Smith DR; Stanley C; Mintz M; McKnight D; Decker A; Tan WH; Tarnopolsky MA; Brady LI; Wolff M; Dondit L; Pedro HF; Parisotto SE; Jones KL; Patel AD; Franz DN; Vanzo R; Marco E; Ranells JD; Di Donato N; Dobyns WB; Laube B; Traynelis SF; Lemke JR
    J Med Genet; 2017 Jul; 54(7):460-470. PubMed ID: 28377535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.